로딩 중…
지수 로딩 중…
Attovia Therapeutics Inc. Common Stock
ATTO· NASDAQ· Health Care
$20.80+2.92%
2026-08-21
Financials
Valuation Metrics
Attovia Therapeutics Inc. Common Stock's Market Cap is $801M. Ranked #2545 of 3,119 in US market (top 82%), #1061 of 1,458 on NASDAQ (top 73%) by Market Cap.
Investment Metrics(as of 2026-08-23)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $801M | US#2,545/3,119 |
| Revenue | $1M | US#2,912/3,119 |
| Net Income | $-61M | US—/3,119 |
| Total Assets | $166M | US#3,019/3,119 |
| Net Assets | $151M | US#2,742/3,119 |
| Employees | 44 | US#2,739/3,119 |
| Value | ||
| P/B | 5.94x | US#2,285/3,119 |
| P/S | 662.97x | US#2,985/3,119 |
| FCF Yield | -7.68% | US—/3,119 |
| Profitability | ||
| ROE | -40.21% | US#2,631/3,119 |
| ROA | -36.55% | US#2,928/3,119 |
| Op. Margin | -4974.74% | US#2,899/3,119 |
| Financial Health | ||
| Debt Ratio | 10.02% | US#110/3,119 |
| Total Debt | $5M | US#2,820/3,119 |
| FCF | $-62M | US#2,551/3,119 |
| Cash | $40M | US#2,671/3,119 |
| Current Ratio | 14.20x | US#103/3,119 |
| Trading | ||
| Volume | 361,555 shares | US#2,200/3,119 |
| Trading Value | $7M | US#2,480/3,119 |
| Per Share | ||
| EPS | $-1.41 | US—/3,119 |
| BPS | $3.50 | US#2,411/3,119 |
Company Info
A clinical-stage biopharmaceutical company developing biotherapeutics for immune-mediated diseases using its ATTOBODY biologics platform. The company's lead candidate, ATTO-1310, targets interleukin-31 (IL-31), known as the 'itch cytokine,' for the treatment of chronic pruritic diseases including atopic dermatitis. Its pipeline also includes multi-specific candidates for other inflammatory diseases.